Value through Innovation27 July 2016

Clinical Study Results

  • GIOTRIF ® (afatinib) - Glioma
    Clinical Study Number 1200.38
    Study Indication Glioma
    Product GIOTRIF ® (afatinib)
    Generic Name Afatinib
    Lab Code
    Clinical Phase I
    Study Title

    Phase I, open label trial to explore safety of combining BIBW 2992 and radiotherapy with or without temozolomide in newly diagnosed GBM

    Study Document Lay summary 1200.38 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.